Correlation Between UNITEDHEALTH and Inhibrx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UNITEDHEALTH and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UNITEDHEALTH and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UNITEDHEALTH GROUP INC and Inhibrx, you can compare the effects of market volatilities on UNITEDHEALTH and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UNITEDHEALTH with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of UNITEDHEALTH and Inhibrx.

Diversification Opportunities for UNITEDHEALTH and Inhibrx

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between UNITEDHEALTH and Inhibrx is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding UNITEDHEALTH GROUP INC and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and UNITEDHEALTH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UNITEDHEALTH GROUP INC are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of UNITEDHEALTH i.e., UNITEDHEALTH and Inhibrx go up and down completely randomly.

Pair Corralation between UNITEDHEALTH and Inhibrx

Assuming the 90 days trading horizon UNITEDHEALTH GROUP INC is expected to generate 3.2 times more return on investment than Inhibrx. However, UNITEDHEALTH is 3.2 times more volatile than Inhibrx. It trades about 0.19 of its potential returns per unit of risk. Inhibrx is currently generating about -0.01 per unit of risk. If you would invest  6,237  in UNITEDHEALTH GROUP INC on September 21, 2024 and sell it today you would earn a total of  1,725  from holding UNITEDHEALTH GROUP INC or generate 27.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

UNITEDHEALTH GROUP INC  vs.  Inhibrx

 Performance 
       Timeline  
UNITEDHEALTH GROUP INC 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in UNITEDHEALTH GROUP INC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, UNITEDHEALTH sustained solid returns over the last few months and may actually be approaching a breakup point.
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

UNITEDHEALTH and Inhibrx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UNITEDHEALTH and Inhibrx

The main advantage of trading using opposite UNITEDHEALTH and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UNITEDHEALTH position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.
The idea behind UNITEDHEALTH GROUP INC and Inhibrx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Correlations
Find global opportunities by holding instruments from different markets